Inventor
ROGELJ SNEZNA
US15 patents
⚠️ This page may combine multiple inventors who share the name “ROGELJ SNEZNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION
6 patentsUS12161689B2Dec 10, 2024
Anti-infective formulations
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION0 citations58
US11554157B2Jan 17, 2023
Anti-infective formulations
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION1 citations58
US12029728B2Jul 9, 2024
Small molecules with anti-protozoan activity
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION0 citations53
US11396497B2Jul 26, 2022
Proteasome inhibitors
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION0 citations47
US10414778B2Sep 17, 2019
Methods for treatment of resistant cancer
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION0 citations46
US10239834B2Mar 26, 2019
Antibiotic sensitivity-restoring and photosensitive agents
NEW MEXICO TECH UNIV RESEARCH PARK CORPORATION0 citations42
NEW MEXICO TECHNICAL RES FOUNDATION
4 patentsUS8946246B2Feb 3, 2015
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
NEW MEXICO TECHNICAL RES FOUNDATION4 citations62
US9334280B2May 10, 2016
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
NEW MEXICO TECHNICAL RES FOUNDATION1 citations42
US9206124B2Dec 8, 2015
Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates
NEW MEXICO TECHNICAL RES FOUNDATION1 citations40
US8349864B2Jan 8, 2013
Pyrano [3,2-C] pyridones and related heterocyclic compounds as pharmaceutical agents for treating disorders responsive to apoptosis, antiproliferation or vascular disruption, and the use thereof
NEW MEXICO TECHNICAL RES FOUNDATION0 citations31